Karin Meiser
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
-
- Multiple Sclerosis Research Studies 2
- Co-authors
- Robert Schmouder (5 shared papers)Luminita Pricop (1 shared paper)Désirée M F M van der Heijde (1 shared paper)Robert Landewé (1 shared paper)Kenneth B. Abrams (1 shared paper)Hasan Tahir (1 shared paper)Shephard Mpofu (1 shared paper)Aimee Readie (1 shared paper)
- Journals
- Blood (1 paper)British Journal of Clinical Pharmacology (1 paper)The Journal of Clinical Pharmacology (1 paper)Annals of Noninvasive Electrocardiology (1 paper)Transplant International (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Karin Meiser
12 papers receiving 575 citations
Karin Meiser's Hit Papers
Peers
Comparison fields: 5 of 46
- Rheumatology 200
- Immunology and Allergy 30
- Immunology 104
- Pathology and Forensic Medicine 57
- Genetics 24
Countries citing papers authored by Karin Meiser
This map shows the geographic impact of Karin Meiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Meiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Meiser more than expected).
Fields of papers citing papers by Karin Meiser
This network shows the impact of papers produced by Karin Meiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Meiser. The network helps show where Karin Meiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Meiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study Hit paper breakdown → | 2018 | 251 |
| 2 | 2016 | 115 | |
| 3 | 2022 | 74 | |
| 4 | 2011 | 58 | |
| 5 | 2022 | 31 | |
| 6 | 2012 | 20 | |
| 7 | 2010 | 11 | |
| 8 | 2014 | 11 | |
| 9 | 2013 | 9 | |
| 10 | 2015 | 4 | |
| 11 | 2011 | 3 | |
| 12 | 2016 | 2 |
About Karin Meiser
Karin Meiser is a scholar working on Pharmacology, Pathology and Forensic Medicine, Transplantation, Cardiology and Cardiovascular Medicine and Physiology, having authored 12 papers that have together received 589 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Multiple Sclerosis Research Studies (2 papers), Asthma and respiratory diseases (2 papers), Immunotoxicology and immune responses (1 paper), Blood Pressure and Hypertension Studies (1 paper), COVID-19 Clinical Research Studies (1 paper) and Reproductive Health and Contraception (1 paper). The work is most often cited by research in Rheumatology (200 citations), Immunology and Allergy (30 citations), Immunology (104 citations), Pathology and Forensic Medicine (57 citations) and Genetics (24 citations). Karin Meiser has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Robert Schmouder, Luminita Pricop, Désirée M F M van der Heijde, Robert Landewé, Kenneth B. Abrams, Hasan Tahir, Shephard Mpofu, Aimee Readie, Proton Rahman and Philip J. Mease. Their work appears in journals such as Blood, British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Annals of Noninvasive Electrocardiology and Transplant International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.